UroGen Pharma stockURGN
UroGen Pharma trades at $25.73, 49.4% below its 52-week high (Aug 19, 2026). The price is below its 50- and 200-day averages, a downtrend. +9.9% year to date, +33.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 18, 2027.
Ratings, candles, signals and the screener for URGN — after you log in
Open the terminalFrequently asked questions about UroGen Pharma
What is the UroGen Pharma stock price?
At the close on Nov 5, 2026: $25.73 (−10.47% on the day). 52-week high: $50.81 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does UroGen Pharma report earnings?
The next quarterly report is on Mar 18, 2027. Last quarter, earnings per share changed +96% year over year, revenue +224%.
Does UroGen Pharma pay dividends?
No, UroGen Pharma does not pay dividends.
Where does UroGen Pharma trade and how to buy it?
Ticker URGN, exchange Nasdaq, listed since 2017. You can buy it through a broker with access to US exchanges.
Should I buy UroGen Pharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for URGN are in the terminal after you log in.